Abbott

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Abbott 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ABT

Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. 

CEO
Robert B. Ford
CEORobert B. Ford
Employees
115,000
Employees115,000
Headquarters
Abbott Park, Illinois
HeadquartersAbbott Park, Illinois
Founded
1888
Founded1888
Employees
115,000
Employees115,000

ABT Key Statistics

Market cap
163.46B
Market cap163.46B
Price-Earnings ratio
25.98
Price-Earnings ratio25.98
Dividend yield
2.62%
Dividend yield2.62%
Average volume
16.11M
Average volume16.11M
High today
$95.21
High today$95.21
Low today
$93.21
Low today$93.21
Open price
$93.86
Open price$93.86
Volume
16.47M
Volume16.47M
52 Week high
$137.54
52 Week high$137.54
52 Week low
$81.97
52 Week low$81.97

Stock Snapshot

With a market cap of 163.46B, Abbott(ABT) trades at $93.81. The stock has a price-to-earnings ratio of 25.98 and currently yields dividends of 2.62%.

On 2026-06-26, Abbott(ABT) stock moved within a range of $93.21 to $95.21. With shares now at $93.81, the stock is trading +0.6% above its intraday low and -1.5% below the session's peak.

Trading volume for Abbott(ABT) stock has reached 16.47M, versus its average volume of 16.11M.

The stock's 52-week range extends from a low of $81.97 to a high of $137.54.

The stock's 52-week range extends from a low of $81.97 to a high of $137.54.

ABT News

Simply Wall St 4h
Abbott Expands In Europe With Instinct CGM And Emerging Market Medicines

Abbott Laboratories (NYSE:ABT) is rolling out its Instinct continuous glucose monitoring sensor across Europe as part of MiniMed insulin pump systems. The inte...

Abbott Expands In Europe With Instinct CGM And Emerging Market Medicines
Barchart 11h
Abbott Laboratories' Q2 2026 Earnings: What to Expect - Barchart.com

...

Abbott Laboratories' Q2 2026 Earnings: What to Expect - Barchart.com
24/7 Wall St. 1d
Buy, Hold, or Sell: Tech Compression Dragged Abbott Labs Under $91, but 1 Massive Diabetes Catalyst Makes It a Screaming Buy

Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Abbott Laboratories didn't make the cut. Grab the names FREE today . Despi...

Buy, Hold, or Sell: Tech Compression Dragged Abbott Labs Under $91, but 1 Massive Diabetes Catalyst Makes It a Screaming Buy

Analyst ratings

79%

of 29 ratings
Buy
79.3%
Hold
20.7%
Sell
0%

More ABT News

Simply Wall St 2d
How An ALZpath Alzheimer’s Test Deal And Dividend Streak At Abbott Has Changed Its Investment Story

In June 2026, Abbott’s board declared a quarterly dividend of US$0.63 per share, marking the company’s 410th consecutive quarterly payout since 1924, payable on...

How An ALZpath Alzheimer’s Test Deal And Dividend Streak At Abbott Has Changed Its Investment Story
24/7 Wall St. 2d
Got $2,500? 1 Unstoppable Dividend Aristocrat With an Ironclad Moat to Buy

Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Abbott Laboratories didn't make the cut. Grab the names FREE today . At $9...

Got $2,500? 1 Unstoppable Dividend Aristocrat With an Ironclad Moat to Buy
Nasdaq 2d
How Are Emerging Markets Supporting Abbott's EPD Momentum?

Abbott’s ABT Established Pharmaceuticals Division (“EPD”) is heavily focused on emerging markets. In the first quarter of 2026, the segment posted 9% year-over-...

How Are Emerging Markets Supporting Abbott's EPD Momentum?
Nasdaq 2d
ALZpath Inks Licensing Deal With Abbott To Expand Blood-Based Alzheimer's Disease Testing

(RTTNews) - Wednesday, ALZpath Inc. announced a licensing agreement with Abbott Laboratories (ABT) to incorporate the company's proprietary phosphorylated Tau 2...

ALZpath Inks Licensing Deal With Abbott To Expand Blood-Based Alzheimer's Disease Testing
TipRanks 2d
Abbott and ALZpath announce license agreement

ALZpath, the leader in blood test-based diagnostic solutions for Alzheimer’s disease, announced a licensing agreement with Abbott (ABT) to incorporate ALZpath’s...

Nasdaq 6d
Should You Buy Abbott Labs Stock Hand Over Fist Before July 16?

Key Points Long-term growth matters more than a single quarter. Abbott benefits from multiple healthcare growth trends. Management's outlook could move share...

Should You Buy Abbott Labs Stock Hand Over Fist Before July 16?
TipRanks 6d
Enphase, Abbott, AmEx, Lowe’s, Bloom: Insider Shockwaves

Insiders have been trading these 5 stocks: ((ENPH)), ((ABT)), ((AXP)), ((LOW)) and ((BE)). Here is a breakdown of their recent trades and their value. Director...

People also own

Based on the portfolios of people who own ABT. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.